Teva Pharmaceuticals USA has voluntarily recalled 6,205 100-count bottles of Actavis Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets (10 mg/10 mg), a prescription medication used to treat nausea and vomiting during pregnancy. The recall was issued because the tablets failed dissolution testing, meaning the active ingredients may not be released into the body at the required rate. This defect could make the medication less effective at managing symptoms. No injuries or incidents have been reported to date. Consumers should consult their healthcare provider or pharmacist regarding their treatment and any remaining medication.
Because the tablets failed to meet dissolution standards, the active ingredients may not be properly absorbed by the patient. This could result in ineffective treatment for nausea and vomiting.
You have 2 options:
Quantity: 6,205 bottles. Manufactured by Actavis Laboratories FL, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.